HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Snyderman, R. Articles by Weinstein, P. Search for Related Content PubMed Articles by Snyderman, R. Articles by Weinstein, P.

Effects of Neoplasms on Inflammation: Depression of Macrophage Accumulation after Tumor Implantation¹

From the Division of Rheumatic and Genetic Diseases, Department of Medicine, Department of Immunology, Duke University Medical Center, Durham, North Carolina 27710

Abstract

The local accumulation of macrophages at sites of neoplasms may be a critical event in immunologically mediated tumor killing. Individuals with neoplasms, however, have been noted to have depressed monocyte chemotactic responsiveness in vitro. To determine the effect of neoplasms on macrophage migration, mice were implanted subcutaneously with either sarcoma or hepatoma cells and their macrophage migratory function quantified in vivo and in vitro. The ability of tumor-bearing animals to mobilize macrophages to an inflammatory site in vivo was depressed by as much as 61% by 6 days after tumor implantation. The in vitro chemotactic responsiveness of macrophages recovered from the peritoneal cavities of tumor-bearing animals was also markedly depressed. Macrophage migration was not affected by implantation of normal syngeneic or allogeneic tissues. In addition, the accumulation of polymorphonuclear leukocytes in vivo was not depressed in tumor-bearing animals. These findings suggest that neoplasms themselves may depress the host's ability to localize macrophages at inflammatory sites in vivo and thereby hinder immunologically mediated tumor destruction.

Footnotes

¹ This work was supported in part by National Institutes of Health Grant 5 R01 DE03738-03 and National Cancer Institute Contract NCI CP 33313.

² Howard Hughes Medical Investigator.

This article has been cited by other articles:

				H. Zhang and A. C. Issekutz Down-Modulation of Monocyte Transendothelial Migration and Endothelial Adhesion Molecule Expression by Fibroblast Growth Factor : Reversal by the Anti-Angiogenic Agent SU6668 Am. J. Pathol., June 1, 2002; 160(6): 2219 - 2230. [Abstract] [Full Text] [PDF]

				R Snyderman and M. Pike An inhibitor of macrophage chemotaxis produced by neoplasms Science, April 23, 1976; 192(4237): 370 - 372. [Abstract] [PDF]